The Valley Desk

NCT02605915 · Interventional trial

Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer

Overall registry status Completed

Phase 1

Conditions HER2-Negative Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer, Locally Advanced or Early Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov